← Leaderboards
Suman Jayadev
University Of Washington
$16,978,735
Attributed
$26,461,079
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,461,079 · 13
By mechanism
R01$9,286,923 · 3
RF1$7,158,431 · 2
P30$6,098,847 · 2
R56$1,811,533 · 2
K08$839,032 · 1
K02$711,180 · 1
Top collaborators
- Jessica Elaine Young8 shared
- Gwenn A Garden6 shared
- Christine M. Disteche5 shared
- Su-In Lee2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Christine M. Disteche$20,986,224
- Jessica Elaine Young$10,314,278
- Gwenn A Garden$13,726,316
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseCellsMicrogliaPathway InteractionsGenesFunctional DisorderCell TypeInflammatory ResponsePathogenesisAutopsyNerve DegenerationBrainImmuneGeneticCytokineComplexInflammatoryCohortDementiaResponseCell LineBrain TissueIn Vitro
Grant awards (39)
Dissecting the role of sex-linked genes and APOE e4 risk in AD$1,166,648
R01 · FY2025 · AG
Clinical Core$953,839
P30 · FY2025 · AG · contact PI
Characterization of AD-related endolysosomal dysfunction in human neural cells$815,882
R01 · FY2025 · AG
Illuminating early microglial dysfunction in Alzheimer's disease through integration of explainable AI and iPSC models$230,642
R21 · FY2025 · AG · contact PI
Dissecting the role of sex-linked genes and APOE e4 risk in AD$1,190,459
R01 · FY2024 · AG
Characterization of AD-related endolysosomal dysfunction in human neural cells$851,663
R01 · FY2024 · AG
Clinical Core$782,492
P30 · FY2024 · AG · contact PI
Illuminating early microglial dysfunction in Alzheimer's disease through integration of explainable AI and iPSC models$191,891
R21 · FY2024 · AG · contact PI
Dissecting the role of sex-linked genes and APOE e4 risk in AD$1,190,459
R01 · FY2023 · AG
Clinical Core$1,091,351
P30 · FY2023 · AG · contact PI
Regulation of diverse microglial phenotypes in neurodegeneration$871,419
R56 · FY2023 · AG · contact PI
Clinical Core$1,335,005
P30 · FY2022 · AG · contact PI
Dissecting the role of sex-linked genes and APOE e4 risk in AD$1,190,459
R01 · FY2022 · AG
Dissecting the role of sex-linked genes and APOE e4 risk in AD$1,190,459
R01 · FY2021 · AG
Clinical Core$1,132,997
P30 · FY2021 · AG · contact PI
Clinical Core$803,163
P30 · FY2020 · AG · contact PI
Understanding the functional impact of cumulative genetic risk in Alzheimer Disease$383,295
RF1 · FY2020 · AG · contact PI
Understanding the functional impact of cumulative genetic risk in Alzheimer Disease$4,186,727
RF1 · FY2019 · AG · contact PI
MicroRNA regulation of central nervous system and systemic inflammation in AD$358,075
RF1 · FY2019 · AG · contact PI
Integrated Cell-type Specific Biological Annotation of Genomic Variants in Alzheimer Disease$940,114
R56 · FY2017 · AG · contact PI
Employing Familial AD Induced Pluripotent Stem Cells to Study Neurodegeneration$141,372
K02 · FY2017 · AG · contact PI
MicroRNA regulation of central nervous system and systemic inflammation in AD$110,823
RF1 · FY2017 · AG · contact PI
Employing Familial AD Induced Pluripotent Stem Cells to Study Neurodegeneration$141,372
K02 · FY2016 · AG · contact PI
MicroRNA regulation of central nervous system and systemic inflammation in AD$2,119,511
RF1 · FY2015 · AG · contact PI
Presenilin 2 and Neuroinflammation$341,250
R01 · FY2015 · NS · contact PI
Employing Familial AD Induced Pluripotent Stem Cells to Study Neurodegeneration$141,372
K02 · FY2015 · AG · contact PI
Presenilin 2 and Neuroinflammation$337,837
R01 · FY2014 · NS · contact PI
Employing Familial AD Induced Pluripotent Stem Cells to Study Neurodegeneration$141,372
K02 · FY2014 · AG · contact PI
Presenilin 2 and Neuroinflammation$329,307
R01 · FY2013 · NS · contact PI
Employing Familial AD Induced Pluripotent Stem Cells to Study Neurodegeneration$145,692
K02 · FY2013 · AG · contact PI
Presenilin 2 and Neuroinflammation$341,250
R01 · FY2012 · NS · contact PI
Presenilin 2 and Neuroinflammation$341,250
R01 · FY2011 · NS · contact PI
The Role of Presenilins in HIV Associated Dementia$167,098
K08 · FY2010 · NS · contact PI
Impact of Presenilin 2 Mutation and Deficiency on Microglial Function$66,300
R03 · FY2010 · AG · contact PI
The Role of Presenilins in HIV Associated Dementia$167,098
K08 · FY2009 · NS · contact PI
Impact of Presenilin 2 Mutation and Deficiency on Microglial Function$66,300
R03 · FY2009 · AG · contact PI
The Role of Presenilins in HIV Associated Dementia$167,098
K08 · FY2008 · NS · contact PI
The Role of Presenilins in HIV Associated Dementia$167,098
K08 · FY2007 · NS · contact PI
The Role of Presenilins in HIV Associated Dementia$170,640
K08 · FY2006 · NS · contact PI